Cargando…

THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function

Disclosure: X. Wang: None. A. Leggieri: None. S. Anagianni: None. C.H. Brennan: None. M. Korbonits: None. Background: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene account for 10% of cases with familial isolated pituitary adenoma (FIPA). The main features of patients carr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xian, Leggieri, Adele, Anagianni, Sofia, Brennan, Caroline H, Korbonits, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553944/
http://dx.doi.org/10.1210/jendso/bvad114.1159
_version_ 1785116294773735424
author Wang, Xian
Leggieri, Adele
Anagianni, Sofia
Brennan, Caroline H
Korbonits, Marta
author_facet Wang, Xian
Leggieri, Adele
Anagianni, Sofia
Brennan, Caroline H
Korbonits, Marta
author_sort Wang, Xian
collection PubMed
description Disclosure: X. Wang: None. A. Leggieri: None. S. Anagianni: None. C.H. Brennan: None. M. Korbonits: None. Background: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene account for 10% of cases with familial isolated pituitary adenoma (FIPA). The main features of patients carrying heterozygous AIP mutations include young-onset, large and invasive growth hormone and/or prolactin-secreting pituitary tumours, although a milder spectrum of presentation has been also described. In several animal models (mouse, fruit fly, round worm), homozygous deletion of AIP results in embryonic mortality. In mice abnormal cardiac development has been observed. Objective: The aim of this study was to generate a zebrafish loss-of-function model to explore the cellular biological processes affected by heterozygous or homozygous aip mutations. Methods: Zebrafish homologue of human AIP was identified by EMBOSS Needle program. We used CRISPR/Cas9 to generate a line of fish carrying loss-of-function mutations targeting zebrafish aip exon 2. aip RNA expression was examined using in situ hybridisation. The growth rate and cardiac function were assessed using a stereo microscope with an integrated camera. The videos and pictures were analysed in ImageJ. Antisense in situ hybridisation with probes to growth hormone 1 (gh1), prolactin (prl) and proopiomelanocortin a (pomca) was used to assess pituitary phenotypes. Results: Zebrafish aip shows 78.8% of homology to human AIP. aip mRNA is expressed throughout the developing zebrafish embryo until 28 hours post fertilisation (hpf) stage when it becomes more strongly expressed in the head. We generated a 29 bp deletion in exon 2 of the zebrafish aip gene. These mutant animals showed reduced aip expression. No significant gross morphology differences were observed at 3 to 7 days post fertilisation (dpf) between wildtype (WT) and heterozygote (Het) animals. At 5dpf, WTs showed an increased heart rate than Hets (P=0.033). Conclusion: We have generated an aip loss of function zebrafish line that provides an ideal opportunity to analyse the role of aip in development. Presentation: Thursday, June 15, 2023
format Online
Article
Text
id pubmed-10553944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105539442023-10-06 THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function Wang, Xian Leggieri, Adele Anagianni, Sofia Brennan, Caroline H Korbonits, Marta J Endocr Soc Neuroendocrinology & Pituitary Disclosure: X. Wang: None. A. Leggieri: None. S. Anagianni: None. C.H. Brennan: None. M. Korbonits: None. Background: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene account for 10% of cases with familial isolated pituitary adenoma (FIPA). The main features of patients carrying heterozygous AIP mutations include young-onset, large and invasive growth hormone and/or prolactin-secreting pituitary tumours, although a milder spectrum of presentation has been also described. In several animal models (mouse, fruit fly, round worm), homozygous deletion of AIP results in embryonic mortality. In mice abnormal cardiac development has been observed. Objective: The aim of this study was to generate a zebrafish loss-of-function model to explore the cellular biological processes affected by heterozygous or homozygous aip mutations. Methods: Zebrafish homologue of human AIP was identified by EMBOSS Needle program. We used CRISPR/Cas9 to generate a line of fish carrying loss-of-function mutations targeting zebrafish aip exon 2. aip RNA expression was examined using in situ hybridisation. The growth rate and cardiac function were assessed using a stereo microscope with an integrated camera. The videos and pictures were analysed in ImageJ. Antisense in situ hybridisation with probes to growth hormone 1 (gh1), prolactin (prl) and proopiomelanocortin a (pomca) was used to assess pituitary phenotypes. Results: Zebrafish aip shows 78.8% of homology to human AIP. aip mRNA is expressed throughout the developing zebrafish embryo until 28 hours post fertilisation (hpf) stage when it becomes more strongly expressed in the head. We generated a 29 bp deletion in exon 2 of the zebrafish aip gene. These mutant animals showed reduced aip expression. No significant gross morphology differences were observed at 3 to 7 days post fertilisation (dpf) between wildtype (WT) and heterozygote (Het) animals. At 5dpf, WTs showed an increased heart rate than Hets (P=0.033). Conclusion: We have generated an aip loss of function zebrafish line that provides an ideal opportunity to analyse the role of aip in development. Presentation: Thursday, June 15, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10553944/ http://dx.doi.org/10.1210/jendso/bvad114.1159 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology & Pituitary
Wang, Xian
Leggieri, Adele
Anagianni, Sofia
Brennan, Caroline H
Korbonits, Marta
THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title_full THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title_fullStr THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title_full_unstemmed THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title_short THU079 Danio Rerio (Zebrafish): A New Model Of AIP Loss Of Function
title_sort thu079 danio rerio (zebrafish): a new model of aip loss of function
topic Neuroendocrinology & Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553944/
http://dx.doi.org/10.1210/jendso/bvad114.1159
work_keys_str_mv AT wangxian thu079danioreriozebrafishanewmodelofaiplossoffunction
AT leggieriadele thu079danioreriozebrafishanewmodelofaiplossoffunction
AT anagiannisofia thu079danioreriozebrafishanewmodelofaiplossoffunction
AT brennancarolineh thu079danioreriozebrafishanewmodelofaiplossoffunction
AT korbonitsmarta thu079danioreriozebrafishanewmodelofaiplossoffunction